Howard H.W. Leung

Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver

Wenshu Tang, Jingying Zhou, Weiqin Yang et al. · Cellular and Molecular Immunology · 2022 · 105 citations · Full text

Life Sciences, Immunology, Oncology +17

Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma

Zhewen Xiong, Stephen L. Chan, Jingying Zhou et al. · Gut · 2023 · 100 citations · Full text

Life Sciences, Immunology, Oncology +17

Association of genetic variations with NAFLD in lean individuals

Huapeng Lin, Grace Lai‐Hung Wong, Carl Whatling et al. · Liver International · 2021 · 78 citations

Life Sciences, Genetics, Molecular Genetics +17

Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma

Julien Caldéraro, Narmin Ghaffari Laleh, Qinghe Zeng et al. · Nature Communications · 2023 · 77 citations · Full text

Medicine, Cancer Biology, Oncology +17

Artificial intelligence in prediction of non‐alcoholic fatty liver disease and fibrosis

Grace Lai‐Hung Wong, Pong C. Yuen, J. Andy et al. · Journal of Gastroenterology and Hepatology · 2021 · 68 citations

Medicine, Biomedical Informatics, Health Informatics +17